Strategies for an HIV Cure (Day 2)
The National Institute of Allergy and Infectious Diseases (NIAID) will host the sixth biennial Strategies for an HIV Cure meeting on October 12-13, 2023. This is a programmatic meeting to review research progress by awardees funded through the NIH Martin Delaney Collaboratories (MDCs) for HIV Cure Research program, foster communication and collaboration between the ten MDCs, and to collect feedback from representatives from each individual MDC Scientific Advisory Board (SAB) and Community Advisory Board (CAB).
The two-day in-person meeting will feature presentations from the ten NIH Martin Delaney Collaboratories for HIV...
Source: Videocast - All Events - September 11, 2023 Category: General Medicine Tags: Upcoming Events Source Type: video
Strategies for an HIV Cure (Day 1)
The National Institute of Allergy and Infectious Diseases (NIAID) will host the sixth biennial Strategies for an HIV Cure meeting on October 12-13, 2023. This is a programmatic meeting to review research progress by awardees funded through the NIH Martin Delaney Collaboratories (MDCs) for HIV Cure Research program, foster communication and collaboration between the ten MDCs, and to collect feedback from representatives from each individual MDC Scientific Advisory Board (SAB) and Community Advisory Board (CAB).
The two-day in-person meeting will feature presentations from the ten NIH Martin Delaney Collaboratories for HIV...
Source: Videocast - All Events - September 11, 2023 Category: General Medicine Tags: Upcoming Events Source Type: video
IIG Seminar: NIH/FDA - Tobias Hohl
All people encounter, inhale, and ingest fungi on a daily basis. Although only several hundred of the estimated five million species of fungi worldwide cause disease in humans, advances in medical technologies and the global AIDS pandemic have dramatically increased our susceptibility to fungal disease. In cancer and bone marrow transplant patients, the filamentous mold Aspergillus fumigatus and the commensal fungus Candida albicans represent significant causes of infection-related morbidity and mortality. At present, no fungal vaccines have been licensed for clinical use, and contemporary antifungal therapies for systemic...
Source: Videocast - All Events - March 3, 2023 Category: General Medicine Tags: Upcoming Events Source Type: video
NIH-FDA Immunology Interest Group 1.11.23
Klaus Fr ü h ’ s research focuses on understanding the molecular interaction between viral pathogens and their hosts, particularly the identification and characterization of viral gene products that modulate the innate and adaptive immune responses. This knowledge is translated into the development and improvement of cytomegalovirus (CMV)-vectored vaccines which are unique in their ability to persistently maintain an immune shield of so called effector memory T cells, including highly unconventional (MHC-II and MHC-E) restricted CD8+ T cells. CMV vectored vaccines have shown protection in non-human primate models of AID...
Source: Videocast - All Events - December 13, 2022 Category: General Medicine Tags: Upcoming Events Source Type: video
COVID-19: Developing a Vaccine During a Pandemic
COVID-19 Scientific Interest GroupDr. Barouch is the William Bosworth Castle Professor of Medicine and Professor of Immunology at Harvard Medical School and director of the Center for Virology and Vaccine Research at the Beth Israel Deaconess Medical Center. His talk will outline the current state of the COVID-19 vaccine field and will describe the development of the Ad26.COV2.S vaccine — a recombinant, replication-incompetent adenovirus serotype 26 (Ad26) vector encoding a full-length and stabilized SARS-CoV-2 spike protein.My laboratory focuses on studying the immunology and virology of HIV-1 infection and developing n...
Source: Videocast - All Events - February 3, 2021 Category: General Medicine Tags: Upcoming Events Source Type: video
COVID 19 Vaccine Development
My laboratory focuses on studying the immunology and virology of HIV-1 infection and developing novel vaccine strategies. I have also recently demonstrated the therapeutic efficacy of potent monoclonal antibodies and the early seeding of the viral reservoir. My laboratory received three NIH U19 Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) program grants in 2005, 2008, and 2012 to construct alternative serotype adenovirus vaccine vectors, to explore their immunogenicity and protective efficacy in rhesus monkeys, and to advance optimal vaccine candidates into clinical trials. Four phase 1 clinical trials...
Source: Videocast - All Events - December 10, 2020 Category: General Medicine Tags: Upcoming Events Source Type: video
The Case for BK Polyomavirus as a Cause of Bladder Cancer
NCI ’ s Center for Cancer Research (CCR) Grand Rounds
Dr. Buck ’ s lab studies polyomaviruses. A great majority of healthy adults chronically shed
polyomavirus virions in their urine and from the surface of their skin. Although these lifelong infections generally aren't known to cause symptoms in healthy individuals, under conditions of immune impairment polyomaviruses can cause disease. For example, BK polyomavirus (BKV) causes kidney and bladder damage in organ transplant patients, while its close relative JCV causes a lethal brain disease in patients on immunosuppressive therapies and in individuals suffering from ...
Source: Videocast - All Events - March 2, 2020 Category: General Medicine Tags: Upcoming Events Source Type: video
Team goes house to house to learn where new vaccine works best (Image 2)
Malaria is endemic in Malawi, especially in the areas around Lake Malawi, the 350-mile-long lake that sits between Malawi, Mozambique and Tanzania. Malawi has a high infant mortality rate, declining life expectancy and an estimated 1 million orphans, mostly because of the HIV/AIDS epidemic. In ...This is an NSF Multimedia Gallery item. (Source: NSF Multimedia Gallery)
Source: NSF Multimedia Gallery - September 15, 2017 Category: Science Source Type: video
CANCELLED - Getting to an Effective HIV Vaccine: Perspectives on Progress
DUE TO THE LIKELIHOOD OF INCLEMENT WEATHER IMPACTING THE DC METRO AREA AND THE NORTHEAST COAST, THIS LECTURE HAS BEEN POSTPONED.
James C. Hill Memorial Lecture
Virologist and vaccine expert Dr. Lawrence Corey will deliver the 2017 James C. Hill Memorial Lecture. His talk, titled “ Getting to an Effective HIV Vaccine: Perspectives on Progress, ” will review the state of HIV vaccine development and describe current strategies to advance the field.
Since 1999, Corey has served as principal investigator of the NIAID-supported HIV Vaccine Trials Network (HVTN), which is dedicated to accelerating development of a safe and ef...
Source: Videocast - All Events - March 13, 2017 Category: Journals (General) Tags: Upcoming Events Source Type: video
Getting to an Effective HIV Vaccine: Perspectives on Progress
James C. Hill Memorial Lecture
Virologist and vaccine expert Dr. Lawrence Corey will deliver the 2017 James C. Hill Memorial Lecture. His talk, titled “ Getting to an Effective HIV Vaccine: Perspectives on Progress, ” will review the state of HIV vaccine development and describe current strategies to advance the field.
Since 1999, Corey has served as principal investigator of the NIAID-supported HIV Vaccine Trials Network (HVTN), which is dedicated to accelerating development of a safe and effective preventive HIV vaccine. The HVTN has built an international scientific collaboration of investigators in 12 countries on ...
Source: Videocast - All Events - February 27, 2017 Category: Journals (General) Tags: Upcoming Events Source Type: video
2016 Kinyoun Lecture - Structure-Based Vaccine Design and B-cell Ontogeny in the Modern Era of Vaccinology
2016 Joseph J. Kinyoun Memorial Lecture
Dr. John Mascola, director of the Dale and Betty Bumpers Vaccine Research Center at NIAID, will deliver the 2016 Joseph J. Kinyoun Memorial Lecture.
His talk, titled “ Structure-Based Vaccine Design and B-cell Ontogeny in the Modern Era of Vaccinology, ” will include an overview of the challenges facing the development of effective vaccines against viruses, including HIV, respiratory syncytial virus and influenza virus. Mascola will describe how researchers can use structural information about viral proteins and antiviral antibodies to design new vaccines. He also will discuss ho...
Source: Videocast - All Events - November 29, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
Oral HPV Continuum: Epidemiology of Oral HPV Infection, Persistence and HPV-related Oropharyngeal Squamous Cell Carcinoma
NIDCR Clinical Research Fellowship Grand Rounds
Oral HPV infection now causes the majority of oropharyngeal (tonsillar) cancers in the U.S. The incidence of HPV-related oropharyngeal cancer is increasing significantly, with men disproportionately affected. This talk reviews what is known about oral HPV infection, its natural history, and the epidemiology of HPV-related oropharyngeal cancers.
Gypsyamber D ’ Souza is an associate professor in epidemiology at the Johns Hopkins Bloomberg School of Public Health, with a joint appointment in the departments of International Health and Otolaryngology-Head and Neck Surgery at th...
Source: Videocast - All Events - September 14, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
Mechanisms of Virus Persistence in Blood and Tissue in HIV Controllers
Immunology Interest Group
Dr. Douek is a Senior Investigator and the Chief of the Human Immunology Section of the Vaccine Research Center, NIAID / NIH. Dr. Douek studied medicine at the Universities of Oxford and London and then practiced internal medicine before pursuing a Ph.D. in Immunology at the University of London. Dr. Douek was appointed to the NIH Vaccine Research Center in November 2000. His laboratory, the Human Immunology Section, studies the processes that determine the course of human diseases in which the immune system, particularly its T cell arm, plays a central role in their pathogenesis and outcome. He ...
Source: Videocast - All Events - June 2, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
Using Data to Save More Lives and Drive Progress Towards the Control of the HIV Epidemic
Ambassador-at-Large Dr. Deborah L. Birx, a renowned HIV/AIDS expert, will deliver the 2015 Joseph J. Kinyoun Memorial Lecture. She will discuss how data are being leveraged to save lives and drive progress toward sustained control of the global HIV/AIDS pandemic.
Birx is the U.S. Global AIDS Coordinator and U.S. Special Representative for Global Health Diplomacy. She oversees implementation of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the largest commitment to combat a single disease by any nation in history.
PEPFAR collects and analyzes data to understand health care service cost, quality and ach...
Source: Videocast - All Events - November 13, 2015 Category: Journals (General) Tags: Upcoming Events Source Type: video
Office of AIDS Research Advisory Council (OARAC) - November 2015
HIV Vaccine Prevention Trials And Emerging OpportunitiesAir date: 11/12/2015 8:30:00 AM (Source: Videocast - All Events)
Source: Videocast - All Events - October 22, 2015 Category: Journals (General) Tags: Upcoming Events Source Type: video
